tiprankstipranks
Trending News
More News >
Biosergen AB (DE:8N1)
:8N1
Germany Market

Biosergen AB (8N1) Income Statement

Compare
1 Followers

Biosergen AB Income Statement

Last quarter (Q2 2025), Biosergen AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Biosergen AB's net income was kr-11.04M. See Biosergen AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 8.57Mkr 4.43M
Gross Profit
kr 0.00kr -456.00Kkr -280.00Kkr -213.60Kkr -6.10M
Operating Expenses
kr 20.69Mkr 26.81Mkr 33.85Mkr 40.68Mkr 6.23M
Depreciation and Amortization
kr 0.00kr 27.27Mkr -5.86Mkr 0.00kr 0.00
EBITDA
kr -19.20Mkr 228.00Kkr -39.99Mkr -34.32Mkr -6.72M
Operating Income
kr -20.69Mkr -27.27Mkr -34.13Mkr -33.71Mkr -6.23M
Other Income/Expenses
kr 1.50Mkr 228.00Kkr 81.00Kkr -612.00Kkr -498.00K
Pretax Income
kr -19.20Mkr -27.04Mkr -34.05Mkr -34.32Mkr -6.72M
Net Income
kr -19.20Mkr -27.04Mkr -34.05Mkr -34.32Mkr -6.72M
Per Share Metrics
Basic EPS
kr -8.00kr -60.00kr -109.00kr -64.00kr -26.00
Diluted EPS
kr -8.00kr -60.00kr -109.00kr -64.00kr -26.00
Weighted Average Shares Outstanding
2.40M 449.26K 527.64K 534.90K 259.98K
Weighted Average Shares Outstanding (Diluted)
2.40M 449.27K 527.64K 534.90K 259.98K
Currency in SEK

Biosergen AB Earnings and Revenue History